{"id":"https://openalex.org/W2538217487","doi":"https://doi.org/10.1016/j.bmcl.2016.10.035","title":"I. Discovery of a novel series of CXCR3 antagonists. Multiparametric optimization of N,N-disubstituted benzylamines","display_name":"I. Discovery of a novel series of CXCR3 antagonists. Multiparametric optimization of N,N-disubstituted benzylamines","publication_year":2016,"publication_date":"2016-10-18","ids":{"openalex":"https://openalex.org/W2538217487","doi":"https://doi.org/10.1016/j.bmcl.2016.10.035","mag":"2538217487","pmid":"https://pubmed.ncbi.nlm.nih.gov/27789137"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2016.10.035","doi":"https://doi.org/10.1016/j.bmcl.2016.10.035","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2016.10.035","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003319104","display_name":"Imre Bata","orcid":"https://orcid.org/0000-0002-8609-4663","observed_orcids":["https://orcid.org/0000-0002-8609-4663"]},"institutions":[{"id":"https://openalex.org/I4210159013","display_name":"Sanofi (Hungary)","ror":"https://ror.org/05bhnz872","country_code":"HU","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210159013"]}],"countries":["HU"],"is_corresponding":true,"raw_author_name":"Imre Bata","raw_affiliation_strings":["Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary. Electronic address: batai@richter.hu","Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary. Electronic address: batai@richter.hu","institution_ids":["https://openalex.org/I4210159013"]},{"raw_affiliation_string":"Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary","institution_ids":["https://openalex.org/I4210159013"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044776112","display_name":"Zsuzsanna T\u00f6m\u00f6sk\u00f6zi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159013","display_name":"Sanofi (Hungary)","ror":"https://ror.org/05bhnz872","country_code":"HU","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210159013"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Zsuzsanna T\u00f6m\u00f6sk\u00f6zi","raw_affiliation_strings":["Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary","institution_ids":["https://openalex.org/I4210159013"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037977060","display_name":"P\u00e9ter Buzder-Lantos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159013","display_name":"Sanofi (Hungary)","ror":"https://ror.org/05bhnz872","country_code":"HU","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210159013"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"P\u00e9ter Buzder-Lantos","raw_affiliation_strings":["Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary","institution_ids":["https://openalex.org/I4210159013"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042727683","display_name":"Attila Vasas","orcid":"https://orcid.org/0000-0003-2415-6360","observed_orcids":["https://orcid.org/0000-0003-2415-6360"]},"institutions":[{"id":"https://openalex.org/I4210159013","display_name":"Sanofi (Hungary)","ror":"https://ror.org/05bhnz872","country_code":"HU","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210159013"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Attila Vasas","raw_affiliation_strings":["Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary"],"raw_orcid":"https://orcid.org/0000-0003-2415-6360","affiliations":[{"raw_affiliation_string":"Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary","institution_ids":["https://openalex.org/I4210159013"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000227288","display_name":"G\u00e1bor Szeleczky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159013","display_name":"Sanofi (Hungary)","ror":"https://ror.org/05bhnz872","country_code":"HU","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210159013"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"G\u00e1bor Szeleczky","raw_affiliation_strings":["Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary","institution_ids":["https://openalex.org/I4210159013"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110087950","display_name":"S\u00e1ndor B\u00e1tori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159013","display_name":"Sanofi (Hungary)","ror":"https://ror.org/05bhnz872","country_code":"HU","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210159013"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"S\u00e1ndor B\u00e1tori","raw_affiliation_strings":["Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary","institution_ids":["https://openalex.org/I4210159013"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015287944","display_name":"Veronika Barta-Bodor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159013","display_name":"Sanofi (Hungary)","ror":"https://ror.org/05bhnz872","country_code":"HU","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210159013"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Veronika Barta-Bodor","raw_affiliation_strings":["Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary","institution_ids":["https://openalex.org/I4210159013"]}]},{"author_position":"middle","author":{"id":null,"display_name":"L\u00e1szl\u00f3 Bal\u00e1zs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159013","display_name":"Sanofi (Hungary)","ror":"https://ror.org/05bhnz872","country_code":"HU","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210159013"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"L\u00e1szl\u00f3 Bal\u00e1zs","raw_affiliation_strings":["Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary","institution_ids":["https://openalex.org/I4210159013"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078470424","display_name":"Gy\u00f6rgy G. Ferenczy","orcid":"https://orcid.org/0000-0002-5771-4616","observed_orcids":["https://orcid.org/0000-0002-5771-4616"]},"institutions":[{"id":"https://openalex.org/I4210159013","display_name":"Sanofi (Hungary)","ror":"https://ror.org/05bhnz872","country_code":"HU","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210159013"]}],"countries":["HU"],"is_corresponding":true,"raw_author_name":"Gy\u00f6rgy G. Ferenczy","raw_affiliation_strings":["Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary. Electronic address: ferenczy.gyorgy@med.semmelweis-univ.hu","Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary"],"raw_orcid":"https://orcid.org/0000-0002-5771-4616","affiliations":[{"raw_affiliation_string":"Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary. Electronic address: ferenczy.gyorgy@med.semmelweis-univ.hu","institution_ids":["https://openalex.org/I4210159013"]},{"raw_affiliation_string":"Sanofi Co. Ltd, H-1045 Budapest, T\u00f3 u. 1-5, Hungary","institution_ids":["https://openalex.org/I4210159013"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5003319104","https://openalex.org/A5078470424"],"corresponding_institution_ids":["https://openalex.org/I4210159013"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":0.6155,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.68436694,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"26","issue":"22","first_page":"5418","last_page":"5428"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.9404000043869019,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0210999995470047,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cxcr3-antagonist","display_name":"CXCR3 antagonist","score":0.9959999918937683},{"id":"https://openalex.org/keywords/chemokine-receptor-antagonists","display_name":"chemokine receptor antagonists","score":0.6930000185966492},{"id":"https://openalex.org/keywords/structure-activity-optimization","display_name":"structure-activity optimization","score":0.8029999732971191},{"id":"https://openalex.org/keywords/metabolic-stability","display_name":"metabolic stability","score":0.5960000157356262},{"id":"https://openalex.org/keywords/liver-microsomes","display_name":"liver microsomes","score":0.8309999704360962},{"id":"https://openalex.org/keywords/caco-2-permeability","display_name":"Caco-2 permeability","score":0.9789999723434448},{"id":"https://openalex.org/keywords/physicochemical-properties","display_name":"physicochemical properties","score":0.7020000219345093},{"id":"https://openalex.org/keywords/computer-aided-drug-design","display_name":"computer-aided drug design","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9367698431015015},{"id":"https://openalex.org/C25532541","wikidata":"https://www.wikidata.org/wiki/Q655541","display_name":"CXCR3","level":5,"score":0.7788888812065125},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.7513612508773804},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.7286806106567383},{"id":"https://openalex.org/C2776276205","wikidata":"https://www.wikidata.org/wiki/Q424000","display_name":"Benzylamine","level":2,"score":0.696315586566925},{"id":"https://openalex.org/C2776200302","wikidata":"https://www.wikidata.org/wiki/Q827450","display_name":"Hepatocyte","level":3,"score":0.5128836631774902},{"id":"https://openalex.org/C2991874392","wikidata":"https://www.wikidata.org/wiki/Q1124842","display_name":"Metabolic stability","level":3,"score":0.4819490611553192},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.4577736556529999},{"id":"https://openalex.org/C2776418720","wikidata":"https://www.wikidata.org/wiki/Q9368","display_name":"Human liver","level":3,"score":0.4575691521167755},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.42602774500846863},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.37954187393188477},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.36892157793045044},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.321353942155838},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.24694561958312988},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.15727955102920532},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.06125307083129883},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.0},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001596","descriptor_name":"Benzylamines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001596","descriptor_name":"Benzylamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001596","descriptor_name":"Benzylamines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054367","descriptor_name":"Receptors, CXCR3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D054367","descriptor_name":"Receptors, CXCR3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2016.10.035","doi":"https://doi.org/10.1016/j.bmcl.2016.10.035","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2016.10.035","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:27789137","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27789137","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.7972999811172485,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1453926756","https://openalex.org/W1640399046","https://openalex.org/W1864636614","https://openalex.org/W1976306345","https://openalex.org/W1989108502","https://openalex.org/W2053384955","https://openalex.org/W2094736478","https://openalex.org/W2097559461","https://openalex.org/W2115289037","https://openalex.org/W2123255618","https://openalex.org/W2140640244","https://openalex.org/W2144940586","https://openalex.org/W2150573491","https://openalex.org/W2298994227","https://openalex.org/W2486243611","https://openalex.org/W2915501178"],"related_works":["https://openalex.org/W2539053807","https://openalex.org/W2023329110","https://openalex.org/W2086482022","https://openalex.org/W1971676818","https://openalex.org/W2949417238","https://openalex.org/W2055299400","https://openalex.org/W2066301424","https://openalex.org/W2058022664","https://openalex.org/W2011445275","https://openalex.org/W1990882094"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-10-28T00:00:00"}